Search results for "Lip"

showing 10 items of 8306 documents

Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

2013

Background & Aims: Unhealthy food intake, specifically fructose, has been associated with metabolic alterations and with the severity of liver fibrosis in patients with non-alcoholic fatty liver disease. In a cohort of patients with genotype 1 chronic hepatitis C (G1 CHC), we tested the association of fructose intake with the severity of liver histology. Methods: Anthropometric and metabolic factors, including waist circumference (WC), waist-to-hip ratio (WHR), dorso-cervical lipohypertrophy and HOMA were assessed in 147 consecutive biopsy-proven G1 CHC patients. Food intake, namely industrial and fruit fructose, was investigated by a three-day structured interview and a computed database. …

AdultLiver CirrhosisMalePathologymedicine.medical_specialtyGenotypeHepatitis C virusLIVER FIBROSISmedicine.disease_causeGastroenterologychemistry.chemical_compoundWaist–hip ratioHcv fructose fibrosisInternal medicineFRUCTOSEmedicineHumansIndustryAgedSettore MED/12 - GastroenterologiaHepatologybusiness.industryFatty liverLipohypertrophyFructoseHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseasechemistryFruitFemaleSteatosisSteatohepatitishepatitis Cbusiness
researchProduct

Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis

1993

Alveolitis of sarcoidosis is characterized by activated alveolar macrophages (AMs) and T cells. The mediators interleukin-1 (IL-1) and interleukin 6 (IL-6) released by AMs represent essential factors for the progression of the T cells in the cell cycle. The role of IL-1 in pulmonary sarcoidosis has previously been studied; however, the relevance of other mediators (i.e. IL-6) has not yet been evaluated. We measured the spontaneous and lipopolysaccharide (LPS)-induced release of IL-6 and tumor necrosis factor alpha (TNF alpha) by bronchoalveolar lavage cells (BAL) and peripheral blood mononuclear cells (PBMNC) in 6 control subjects (group A) and in 15 patients with sarcoidosis, 10 with activ…

AdultLung DiseasesMalePulmonary and Respiratory Medicinemedicine.medical_specialtySarcoidosisLipopolysaccharidePeripheral blood mononuclear cellchemistry.chemical_compoundInternal medicineHumansMedicineInterleukin 6AgedLungmedicine.diagnostic_testbiologyInterleukin-6Tumor Necrosis Factor-alphabusiness.industryMiddle AgedCell cyclemedicine.diseaseBronchoalveolar lavageEndocrinologymedicine.anatomical_structurechemistryImmunologybiology.proteinFemaleTumor necrosis factor alphaSarcoidosisbusinessBronchoalveolar Lavage FluidLung
researchProduct

Imaging of the lungs using 3he MRI: Preliminary clinical experience in 18 patients with and without lung disease

1997

The purpose of this study was to describe the 3He MRI findings of normal pulmonary ventilation in healthy volunteers and to evaluate abnormalities in patients with different lung diseases. Hyperpolarized 3He gas (300 ml, 3 x 10(5) Pa, polarized to 35-45% by optical pumping, provided in special glass cells) was inhaled by 8 healthy volunteers and 10 patients with different lung diseases. Imaging was performed with a three-dimensional fast low-angle shot (FLASH) sequence (TR = 11.8 msec; TE = 5 msec; transmitter amplitude, 5-8 V; corresponding flip angle, < 5 degrees) in a single breath-hold (22-42 seconds). Clinical and radiological examinations were available for correlation. The studies we…

AdultLung DiseasesMalemedicine.medical_specialtyPleural effusionHyperpolarized Helium 3HeliumSensitivity and SpecificityDiagnosis DifferentialFlip angleHumansMedicineRadiology Nuclear Medicine and imagingLung Diseases ObstructiveLungAgedLungBronchiectasismedicine.diagnostic_testbusiness.industryMagnetic resonance imagingMiddle AgedImage Enhancementmedicine.diseaseMagnetic Resonance ImagingObstructive lung diseaseRespiratory Function TestsHypoventilationmedicine.anatomical_structureFemaleRadiologymedicine.symptomPulmonary VentilationTomography X-Ray ComputedbusinessJournal of Magnetic Resonance Imaging
researchProduct

Identification of a Lipid Transfer Protein as a New Allergen From Morus alba Pollen.

2017

AdultMale010504 meteorology & atmospheric sciencesImmunologymedicine.disease_cause01 natural sciences03 medical and health sciencesYoung Adult0302 clinical medicineAllergenPollenBotanymedicineImmunology and AllergyHumans0105 earth and related environmental sciencesPlant Proteinsbiologybusiness.industryRhinitis Allergic SeasonalAllergensAntigens PlantMiddle Aged030228 respiratory systemProfilinbiology.proteinPollenIdentification (biology)Electrophoresis Polyacrylamide GelFemaleMorusbusinessCarrier ProteinsPlant lipid transfer proteinsJournal of investigational allergologyclinical immunology
researchProduct

Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancer

2019

Abstract Background and objectives Pre-clinical data have shown that combining trifluridine/tipiracil with oxaliplatin enhances anti-tumour activity compared with either monotherapy. A phase I dose-escalation study was conducted to determine the maximum tolerated dose (MTD), recommended dose (RD) for phase II and pharmacokinetic profile of this combination in patients with metastatic colorectal cancer (mCRC) who had progressed after at least 1 prior line of treatment. Methods Using a 3 + 3 design, patients received escalating trifluridine/tipiracil doses from 25, then 30 and to 35 mg/m2 twice daily, days 1–5, q14 days, together with a fixed dose of 85 mg/m2 of oxaliplatin day 1, q14 days. A…

AdultMale0301 basic medicineCancer Researchmedicine.medical_specialtyPyrrolidinesMaximum Tolerated DoseNauseaTrifluridineNeutropeniaGastroenterologyTrifluridine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineUracilAdverse effectneoplasmsAgedTipiracilbusiness.industryMiddle Agedmedicine.diseaseOxaliplatinOxaliplatinDrug Combinations030104 developmental biologyOncologychemistry030220 oncology & carcinogenesisVomitingFemalemedicine.symptomColorectal NeoplasmsbusinessThymineFebrile neutropeniamedicine.drugEuropean Journal of Cancer
researchProduct

Cholelithiasis in Patients with Gaucher Disease type 1: Risk Factors and the Role of ABCG5/ABCG8 Gene Variants

2016

Background &amp; Aim: Patients with Gaucher disease type 1 (GD1) show an altered lipid profile and a certain degree of insulin resistance, which might contribute to cholelithiasis (CL) and could possibly be associated with ABCG5/ABCG8 gene variants. We aimed to investigate the prevalence of CL in Caucasian adult patients with GD1 and the possible risk factors, including gene variants of the ABCG5/ABCG8 genes.&#x0D; Methods: 61 Caucasian patients with GD1 (38 female/23male), aged 18-62 years and 61 healthy subjects matched for age, gender and BMI, without CL, for comparison of lipid profiles. Data before start of enzyme replacement therapy (ERT) were recorded: clinical, haematological, sever…

AdultMale0301 basic medicineHeterozygotemedicine.medical_specialtyAdolescentLipoproteinsmedicine.medical_treatmentSplenectomyABCG8030105 genetics & heredityGastroenterologyWhite PeopleYoung Adult03 medical and health sciencesInsulin resistanceGene FrequencyCholelithiasisRisk FactorsInternal medicineGenotypePrevalencemedicineHumansEnzyme Replacement TherapyGenetic Predisposition to DiseaseATP Binding Cassette Transporter Subfamily G Member 5Genetic Association StudiesGaucher Diseasemedicine.diagnostic_testRomaniabusiness.industryATP Binding Cassette Transporter Subfamily G Member 8HomozygoteGastroenterologyCase-control studyGenetic VariationEnzyme replacement therapyMiddle Agedmedicine.diseaseCross-Sectional StudiesPhenotypeCase-Control StudiesGlucosylceramidaseFemaleLipid profilebusinessDyslipidemiaJournal of Gastrointestinal and Liver Diseases
researchProduct

Emotional eating as a mediator between anxiety and cholesterol in population with overweight and hypertension

2016

Although the relationship between cholesterol and mood states (especially anxiety) has been well studied, few researches have included the role of eating styles in this relationship. This study explored the associations among eating styles, negative emotional symptoms, and levels of cholesterol (and other medical variables) in a population with hypertension and overweight or obesity, analyzing the possible mediation mechanisms involved. A cross-sectional study was conducted in 68 adults with hypertension and overweight/obesity, and stepwise multiple regression analysis and mediation analyses were carried out to test the hypothesis that eating styles mediate the relationship between negative…

AdultMale0301 basic medicineMediation (statistics)medicine.medical_specialtyHypercholesterolemiaStatistics as TopicPopulation030204 cardiovascular system & hematologyOverweightHigh cholesterol03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesmedicineHumansAffective SymptomsPsychiatryeducationApplied PsychologyAgededucation.field_of_study030109 nutrition & dieteticsFeeding BehaviorMiddle AgedOverweightEmotional eatingmedicine.diseaseAnxiety DisordersObesityPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesMoodHypertensionAnxietyFemalelipids (amino acids peptides and proteins)medicine.symptomPsychologyClinical psychologyPsychology, Health &amp; Medicine
researchProduct

Active paraplegics are protected against exercise-induced oxidative damage through the induction of antioxidant enzymes

2016

Exercise improves functional capacity in spinal cord injury (SCI). However, exhaustive exercise, especially when sporadic, is linked to the production of reactive oxygen species that may have a detrimental effect on SCI. We aimed to study the effect of a single bout of exhaustive exercise on systemic oxidative stress parameters and on the expression of antioxidant enzymes in individuals with paraplegia. The study was conducted in the Physical Therapy department and the Physical Education and Sports department of the University of Valencia. Sixteen paraplegic subjects were submitted to a graded exercise test (GET) until volitional exhaustion. They were divided into active or non-active group…

AdultMale0301 basic medicinePathologymedicine.medical_specialtyAntioxidantNeurologyEnzimasmedicine.medical_treatmentEnzimaPharmacologyAntioxidantsProtein CarbonylationOxidative damage03 medical and health sciences0302 clinical medicineMalondialdehydeAccelerometrymedicineHumansRNA MessengerExerciseSpinal cord injuryAgedParaplegiachemistry.chemical_classificationGlutathione PeroxidaseParaplejíaSuperoxide Dismutasebusiness.industryGeneral MedicineMiddle AgedCatalasemedicine.disease030104 developmental biologyEnzymeGene Expression RegulationNeurologychemistryExercise TestLeukocytes MononuclearFemaleLipid PeroxidationNeurology (clinical)ParaplegiabusinessEnfermedad030217 neurology & neurosurgery
researchProduct

Kosaki overgrowth syndrome: A novel pathogenic variant in PDGFRB and expansion of the phenotype including cerebrovascular complications

2020

Heterozygous activating variants in platelet-derived growth factor, beta (PDGFRB) are associated with phenotypes including Kosaki overgrowth syndrome (KOGS), Penttinen syndrome and infantile myofibromatosis (IM). Here, we present three new cases of KOGS, including a patient with a novel de novo variant c.1477A > T p.(Ser493Cys), and the oldest known individual age 53 years. The KOGS phenotype includes characteristic facial features, tall stature, scoliosis, hyperelastic thin skin, lipodystrophy, variable intellectual and neurological deterioration, and abnormalities on brain imaging. Long-term outcome is unknown. Our cases confirm the phenotypic spectrum includes progressive flexion contrac…

AdultMale0301 basic medicinePathologymedicine.medical_specialtyInfantile myofibromatosisPDGFRBScoliosis030105 genetics & heredityCraniosynostosisReceptor Platelet-Derived Growth Factor beta03 medical and health sciencesCamptodactylyGeneticsmedicineHumansJoint dislocationStrokeGrowth DisordersGenetics (clinical)business.industryGenetic VariationMiddle Agedmedicine.diseaseCerebrovascular DisordersPhenotype030104 developmental biologymedicine.symptomLipodystrophybusinessClinical Genetics
researchProduct

Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B

2017

To evaluate the natural course of disease progression in patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB), identify potential end points for future therapy trials, and characterize biomarkers related to the disease.A prospective, multicenter study was conducted. Baseline, 6-month, and 12-month assessments included neurodevelopmental status (Bayley Scales of Infant Development, Third edition), adaptive status (Vineland Adaptive Behavior Scales, Second Edition), volumetric brain magnetic resonance imaging, cerebrospinal fluid heparan sulfate, and urine glycosaminoglycan (GAG) measurements.Nineteen patients aged 1.6-31.7 years were enrolled. Over 12 months, cognition,…

AdultMale0301 basic medicinePediatricsmedicine.medical_specialtyAdolescentDiseaseBayley Scales of Infant DevelopmentMucopolysaccharidosis IIIYoung Adult03 medical and health sciences0302 clinical medicineMucopolysaccharidosis IIImedicineHumansLongitudinal StudiesProspective StudiesYoung adultChildProspective cohort studyCerebrospinal FluidGlycosaminoglycansSanfilippo syndromemedicine.diagnostic_testbusiness.industryBrainInfantMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingVineland Adaptive Behavior Scale030104 developmental biologyNeurodevelopmental DisordersChild PreschoolPediatrics Perinatology and Child HealthDisease ProgressionFemaleHeparitin SulfatebusinessBiomarkers030217 neurology & neurosurgeryThe Journal of Pediatrics
researchProduct